Axithra

Developer of a therapeutic drug monitoring platform based on optical technology. The company's technology platform is based on chip-based Raman spectroscopy, which uses laser light to measure the concentration of beta-blockers, immunosuppressants, and other drugs in patients blood, which can help healthcare providers to optimize drug dosages and improve patient outcomes. Founded in 2023, headquartered in Ghent, Belgium. The company has raised $10.7M in funding at the seed stage. The team compris The company operates in High Tech > Wearable Technology, Internet of Things - Industry Applications > Wearable Technology, HealthTech > Healthcare IT. Its business models include Wearable Technology > Health and Wellness Devices > Remote Patient Monitoring, Healthcare IT > Value Based Care > Remote Monitoring > Hardware > Wearables > Therapeutic Drug Monitoring. Founded in 2023. Headquartered in Belgium, Ghent. The company has raised funding at the Seed stage. Backed by investors including imec.xpand, Kurma Partners, Qbic Fund, Noshaq, White Fund, Wallonie Entreprendre, Hamamatsu Photonics, Werfen, We Venture Capital.